"Research Communications Senior Writer"

Dr. Li is widely recognized for his pioneering contributions at the interface of immune regulation, proteostasis, and translational immuno-oncology. Over the past two decades, his laboratory has established key principles linking endoplasmic reticulum (ER) proteostasis to immune function. His team was among the first to apply mammalian genetics to elucidate the in vivo roles of GRP94/gp96, an ER-resident HSP90 paralog, demonstrating its function as a client-restricted, ATP-dependent immune chaperone essential for the organization of Toll-like receptors, integrins, Wnt co-receptors, the GARPTGF-β axis, and platelet biology. These discoveries helped launch the field of immune chaperone biology and have produced multiple translational innovations, including gp96-based cancer vaccines and first-in-human anti-GARP CAR-T therapies.

The Research Communications Senior Writer will collaborate closely with the Li Lab to translate scientific concepts, discoveries, and ongoing initiatives into clear, accurate, and compelling written materials. Responsibilities will include the development of manuscripts, grant applications, post-award scientific reports, industry-sponsored research agreements, patent-related documents, clinical trial protocols, IND applications, scientific presentations, research process documentation, and strategic communications such as marketing materials. Through these efforts, the Senior Writer will support the laboratorys mission by effectively communicating the significance, innovation, and impact of PIIOs research at the forefront of immuno-oncology.

MINIMUM REQUIRED QUALIFICATIONS
Bachelor's degree or equivalent experience. Advanced degree in relevant field may be desirable. 4 years of relevant experience required. 4-8 years of relevant experience preferred.

Function: Marketing and Communications
Sub Function: Research Communications
Career Band: Individual Contributor - Specialized
Career Level: S3

The OSUCCC James is the only cancer program in the United States that features a National Cancer Institute (NCI)-designated comprehensive cancer center aligned with a nationally ranked academic medical center and a freestanding cancer hospital on the campus of one of the nations largest public universities.

The Pelotonia Institute for Immuno-Oncology (PIIO) is a comprehensive bench-to-bedside research enterprise focused on advancing cancer immunotherapy through fundamental discovery, translational research, and clinical innovation.